Episode # 6 • 23 Sept 2025
Percutaneous Ventricular Assist Devices (pVADs)
It’s no shock that percutaneous ventricular assist devices (pVADs) play an important role in improving cardiogenic shock outcomes (pun intended). In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo interviews Dr. Babar Basir, a renowned interventional cardiologist from Michigan, about advancements and protocols in managing cardiogenic shock.
Timestamps
00:00 - Introduction
03:50 - Impella in Shock: From Last-Resort to Early Use
07:30 - National Cardiogenic Shock Initiative
14:30 - Heart Failure Readmissions
17:46 - Additional Indications for Use of Impella Device
24:10 - Future Devices and Technological Advancements in the Field
27:03 - International Advancements in Shock Initiative Protocols
30:28 - Using Impella CP vs Impella 5.5
38:20 - SCAI Shock Conference and Importance of Attending
Resources
You may also like
More about this episode
Dr. Babar Basir details the history and development of the cardiogenic shock program initiated at Henry Ford Hospital, its national expansion, and its impact on patient outcomes. The conversation touches on the role of advanced heart failure specialists, ongoing trials like the Door to Unload trial, and the importance of small bore mechanical circulatory support devices. Dr. Babar Basir also highlights the significance of team-based approaches and the necessity of multidisciplinary care in improving survival rates for patients suffering from cardiogenic shock.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.